-
2 weeks ago | 
insights.citeline.com | Andrew Warmington
-
1 month ago | 
specchemonline.com | Andrew Warmington
Indian CDMO Shilpa Biologicals has opened a dedicated bioconjugation alongside its commercial biologics manufacturing facility in Dharwad. This is currently undergoing validation and is expected to begin onboarding client programmes by September. The new suite is built to support the manufacture of antibody-drug conjugates (ADCs) and other advanced bioconjugates. It includes 200L single-use bioconjugation reactors and a lyophilisation capacity of up to 65 kg.
-
2 months ago | 
insights.citeline.com | Andrew Warmington
Richard DiMarchi On The GLP-1 Revolution: An Overnight Success After 40 YearsAs GLP-1 agonists surge to blockbuster status transforming diabetes and obesity treatment, Richard DiMarchi, the pioneering scientist behind their development, recounts the inside story of the drug class in a fireside chat. Richard DiMarchi (Marc Lebryk/Marc Lebryk)
-
Mar 12, 2025 | 
specchemonline.com | Andrew Warmington
Czech firm Draslovka has formed an R&D partnership with Natron Energy to develop and produce Prussian blue material required for its proprietary sodium-ion battery technologies. The agreement envisages a layered scope of co-operation across Draslovka’s areas of expertise, using its research, production and logistics capabilities on both sides of the Atlantic.
-
Mar 12, 2025 | 
specchemonline.com | Andrew Warmington
Rainbow North America, the US subsidiary of a Chinese crop protection firm, has established a ‘partner production centre’ at Champaign, Illinois, in the heart of the Midwestern agricultural sector. This will begin with a renovation and construction activities on a 12-hectare campus and will continue with multi-phase expansion. Production operations will be in place to support the 2026 growing season.
-
Mar 12, 2025 | 
specchemonline.com | Andrew Warmington
Submitted by: Andrew Warmington CDMO Axplora has opened a GMP workshop at its Le Mans site to make payloads for ADCs. Features include three Hastelloy reactors with a production range of 30-200 L, plus space for a fourth, and a dedicated Hastelloy filter dryer for high-level containment and safety. It can produce batches of up to 1.5 kg. This is part of the France 2030 programme.
-
Mar 12, 2025 | 
specchemonline.com | Andrew Warmington
Submitted by: Andrew Warmington Following approvals from regulators and shareholders, India’s Sudarshan Chemical Industries (SCIL) has completed its acquisition of Germany-based Heubach Group, the world’s second largest pigment player, in a combined asset and share deal. Terms were not disclosed. The combined firm will have 19 sites.
-
Mar 3, 2025 | 
specchemonline.com | Andrew Warmington
Submitted by: Andrew Warmington Italy’s RadiciGroup has signed a definitive agreement to sell its Specialty Chemicals and High Performance Polymers business areas to an affiliate of Dallas-based private equity firm Lone Star Funds. Terms were not disclosed and the deal should close in 2H, subject to customary closing conditions and regulatory approvals.
-
Mar 3, 2025 | 
specchemonline.com | Andrew Warmington
Submitted by: Andrew Warmington CDMO Granules India has agreed to acquire Senn Chemicals, as Swiss specialist in liquid- and solid-phase peptide synthesis in a deal that should close within 1H, subject to regulatory approvals. Terms were not disclosed. The two companies have already been collaborating on two GLP-1-based APIs for anti-diabetic and anti-obesity therapeutics, a booming area in which Granules wants to expand.
-
Mar 3, 2025 | 
specchemonline.com | Andrew Warmington
International Process Plants (IPP) has leased a 151 million L/year precision fermentation plant in Little Falls, Minnesota (pictured), to Nuol Green Chemistry, which will use it to produce biochemicals including isobutanol and acetone. Nuol uses fermentation, low-pressure hydrogenation, esterification, transesterification and other technologies to develop biobased alternatives for industries such as cosmetics, pharmaceuticals, food and biofuels.
